Hudson Bay Capital Management’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
-55,000
| Closed | -$510K | – | 1394 |
|
2022
Q1 | $510K | Buy |
+55,000
| New | +$510K | 0.01% | 850 |
|
2021
Q4 | – | Sell |
-95,000
| Closed | -$3.23M | – | 1214 |
|
2021
Q3 | $3.23M | Sell |
95,000
-152,500
| -62% | -$5.18M | 0.04% | 488 |
|
2021
Q2 | $9.06M | Buy |
247,500
+17,500
| +8% | +$641K | 0.11% | 147 |
|
2021
Q1 | $10.3M | Buy |
230,000
+25,000
| +12% | +$1.12M | 0.13% | 111 |
|
2020
Q4 | $11.7M | Buy |
205,000
+5,000
| +3% | +$285K | 0.13% | 95 |
|
2020
Q3 | $10.3M | Sell |
200,000
-10,000
| -5% | -$513K | 0.15% | 106 |
|
2020
Q2 | $12.5M | Buy |
210,000
+50,000
| +31% | +$2.99M | 0.22% | 69 |
|
2020
Q1 | $6.59M | Buy |
160,000
+25,000
| +19% | +$1.03M | 0.17% | 110 |
|
2019
Q4 | $8.4M | Sell |
135,000
-130,000
| -49% | -$8.09M | 0.19% | 93 |
|
2019
Q3 | $8.99M | Buy |
265,000
+20,000
| +8% | +$679K | 0.25% | 77 |
|
2019
Q2 | $5.53M | Buy |
245,000
+113,705
| +87% | +$2.56M | 0.13% | 139 |
|
2019
Q1 | $3.05M | Buy |
+131,295
| New | +$3.05M | 0.04% | 224 |
|
2018
Q2 | – | Sell |
-125,000
| Closed | -$2.51M | – | 655 |
|
2018
Q1 | $2.51M | Sell |
125,000
-95,000
| -43% | -$1.9M | 0.05% | 220 |
|
2017
Q4 | $4.99M | Buy |
220,000
+20,000
| +10% | +$453K | 0.11% | 108 |
|
2017
Q3 | $3.8M | Buy |
+200,000
| New | +$3.8M | 0.09% | 134 |
|